<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://majorhealthnews.com/press-releases/aprea-therapeutics-announces-interim-results-from-the-ongoing-first-in-human-phase-1</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-20T14:21:23.536Z</news:publication_date><news:title>Aprea Therapeutics Announces Interim Results From the Ongoing First-in-human Phase 1 Study of WEE1 Inhibitor APR-1051 in Patients with Advanced Solid Tumors (ACESOT-1051) at the 38th EORTC-NCI-AACR Symposium in Barcelona</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/tvardi-therapeutics-advances-next-generation-oral-stat3-inhibitor-tti-109-toward-ind-in</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T13:30:59.651Z</news:publication_date><news:title>Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/biohavens-novel-fgfr3-directed-adc-with-proprietary-topoix-payload-bhv-1530-shows</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T12:45:59.140Z</news:publication_date><news:title>Biohaven's Novel FGFR3-Directed ADC with Proprietary TopoIx Payload, BHV-1530, Shows Clinical Activity and Confirmed Responses in FGFR3-Altered Urothelial and Head and Neck Cancers, Oral Presentation at ENA 2026</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/kazia-therapeutics-announces-filing-of-annual-report-on-form-20-f-for-fiscal-year-ended</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T12:07:10.175Z</news:publication_date><news:title>Kazia Therapeutics Announces Filing of Annual Report on Form 20-F for Fiscal Year Ended June 30, 2026</news:title></news:news></url>
</urlset>